iKena Oncology appoints Yarema as CEO of ImageneBio

Written by Emily J. Thompson, Senior Investment Analyst

IKNA%

PSTX%

Updated: Jul 23 2025

0mins

New Leadership Appointment: Ikena Oncology has appointed Kristin Yarema, Ph.D. as the Chief Executive Officer of ImageneBio following the anticipated closing of their merger.
Previous Experience: Dr. Yarema previously served as President and CEO at Poseida Therapeutics and was also a member of its Board of Directors.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

iKena Oncology appoints Yarema as CEO of ImageneBio

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Trump Administration Requires Tech Firms to Fund $15B Power Generation Plan

IonQ Advances in Quantum Computing with Over $68 Million Revenue in 2025

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch